Siemens reacts with lightning speed
The markets are dominated by tariffs and trade disputes, but the DAX is showing encouraging signs of easing. In this environment in particular, Siemens $SIE (-0,86 %) as one of the major players in medical technology. The ability to react quickly to changing conditions is crucial today in order to survive in international competition. Siemens has already developed strategies to meet the challenges posed by geopolitical tensions and to secure its market position. In the past, the company has proven time and again that it is flexible enough to adapt to new circumstances and thus maintain its innovative strength.
China's retaliation hits German medical technology companies
In the USA, China has responded to the recently introduced EU restrictions by drastically limiting imports of medical technology from Europe. This measure has already had a noticeable impact on the stock market, where the shares of companies such as Siemens Healthineers $SHLMerck KGaA $MRK (-1,71 %) and Carl Zeiss Meditec $AFX (+1,18 %) have fallen by up to 2.7 percent. The new regulations, which came into force on July 6, force Chinese institutions to exclude European suppliers from public tenders if the procurement value exceeds 45 million yuan. Analysts warn that although these retaliatory measures benefit Chinese manufacturers in the short term, trade barriers are detrimental to all parties involved in the long term. In June, the EU Commission decided to exclude Chinese companies from state purchases, which is interpreted as a reaction to the unequal competitive conditions in China. It is clear that despite short-term advantages for certain players, the long-term effects on the market and the innovative strength of the medical technology sector should not be neglected.
Sources: